GBA1 and Gaucher disease: The first enzyme to be used in the treatment of patients with Gaucher disease was mannose terminated human placental glucocerebrosidase, alglucerase (Ceredase®), which was replaced in 1994 by its recombinant form, imiglucerase (Cerezyme®), (both manufactured by Genzyme Corporation, Cambridge, MA, USA).